• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Stent implantation and balloon dilatation in the treatment of stenosis and obstruction of the lacrimal apparatus].

作者信息

Wilhelm K, Textor J, Hofer U, Böker T, Strunk H, Schild H

机构信息

Radiologische Universitätsklinik, Rheinische Friedrich-Wilhelms-Universität, Bonn.

出版信息

Rofo. 1997 Nov;167(5):486-90. doi: 10.1055/s-2007-1015568.

DOI:10.1055/s-2007-1015568
PMID:9440894
Abstract

PURPOSE

To evaluate treatment of epiphora caused by obstructions of the nasolacrimal duct system with balloon dilatation and stent implantation.

MATERIAL AND METHODS

28 dacryocystoplasties were performed in 20 patients with complete (n = 7) or incomplete (n = 13) obstruction of the nasolacrimal duct system.

RESULTS

Dacryocystoplasty was technically successful performed in 26 cases (93%). Recanalisation was not achieved in two patients with complete obstructions. 17 patients showed complete or partial resolution of epiphora during follow-up of up to two years (clinical success 85%). Complete reobstruction occurred only in one patient 9 months after balloon dilatation and recanalisation was not possible.

CONCLUSION

With a technical success rate of 93% and a clinical success rate of 85% dacryocystoplasty is a non-operative alternative for treatment of epiphora caused by obstructions of the nasolacrimal duct system.

摘要

相似文献

1
[Stent implantation and balloon dilatation in the treatment of stenosis and obstruction of the lacrimal apparatus].
Rofo. 1997 Nov;167(5):486-90. doi: 10.1055/s-2007-1015568.
2
[Balloon dilatation and Stentimplantation of the nasolacrimal duct for chronic epiphora].鼻泪管球囊扩张及支架植入治疗慢性泪溢
Ophthalmologe. 2005 Apr;102(4):375-86. doi: 10.1007/s00347-004-1111-4.
3
Clinical effectiveness of balloon dacryocystoplasty in circumscribed obstructions of the nasolacrimal duct.球囊泪囊成形术治疗鼻泪管局限性阻塞的临床疗效
Ophthalmologica. 2007;221(6):434-8. doi: 10.1159/000107507.
4
Nonsurgical fluoroscopically guided dacryocystoplasty of common canalicular obstructions.
Cardiovasc Intervent Radiol. 2000 Jan-Feb;23(1):1-8. doi: 10.1007/s002709910001.
5
Nonsurgical placement of a nasolacrimal polyurethane stent: long-term effectiveness.鼻泪管聚氨酯支架的非手术置入:长期疗效
Radiology. 1996 Sep;200(3):759-63. doi: 10.1148/radiology.200.3.8756928.
6
Obstructed nasolacrimal duct system in epiphora: long-term results of dacryocystoplasty by means of balloon dilation.
Radiology. 1997 Dec;205(3):791-6. doi: 10.1148/radiology.205.3.9393537.
7
Balloon dacryocystoplasty: indications and contraindications.
Radiology. 1997 Dec;205(3):785-90. doi: 10.1148/radiology.205.3.9393536.
8
Complete obstruction of the nasolacrimal system. Part II. Treatment with expandable metallic stents.鼻泪系统完全阻塞。第二部分。可扩张金属支架治疗。
Radiology. 1993 Feb;186(2):372-6. doi: 10.1148/radiology.186.2.8421737.
9
Dacryocystoplasty: treatment of epiphora by means of balloon dilation of the obstructed nasolacrimal duct system.泪囊成形术:通过对阻塞的鼻泪管系统进行球囊扩张来治疗溢泪。
Radiology. 1994 Nov;193(2):453-6. doi: 10.1148/radiology.193.2.7972762.
10
Efficacy of mitomycin-C irrigation after balloon dacryocystoplasty.
J Vasc Interv Radiol. 2007 Jun;18(6):757-62. doi: 10.1016/j.jvir.2007.04.001.

引用本文的文献

1
[Dacryocystorhinostomy as part of the interdisciplinary treatment of lacrimal duct].
HNO. 2013 Oct;61(10):851-8. doi: 10.1007/s00106-013-2672-9.
2
[Importance of imaging diagnostics and interventional therapy for diseases of the lacrimal drainage canals].[泪道疾病的影像诊断与介入治疗的重要性]
Radiologe. 2008 Dec;48(12):1155-60. doi: 10.1007/s00117-008-1695-9.
3
[Balloon dilatation of the canaliculus communis for chronic epiphora].
Ophthalmologe. 2005 Apr;102(4):369-74. doi: 10.1007/s00347-004-1112-3.